Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 850 for “"Triple-Negative Breast Cancer"”.
-
Triple negative breast cancer-An Overview
Ο τριπλά αρνητικός καρκίνος του μαστού χαρακτηρίζεται από αρνητικούς υποδοχείς οιστρογόνων (ER), αρνητικούς υποδοχείς προγεστερόνης (PR) και αρνητικούς υποδοχείς HER2. Αποτελεί μια ετερογενή ομάδα, και τα χαρακτηριστικά αυτά συνολικά ανευρίσκονται σε 15-20% των περιπτώσεων καρκίνου του μαστού. O …
-
The Biology of Triple Negative Breast Cancer
Breast cancer is the most diagnosed cancer among women worldwide and remains a leading cause of cancer-related mortality. Among its subtypes, triple-negative breast cancer (TNBC) is the most aggressive, accounting for 15–20% of all breast cancer cases. TNBC is defined by the absence of estrogen …
-
CircREV1 Expression in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) comprises only 24% of breast cancer cases, yet is the second leading cause of cancer mortality in women due to its aggressive nature (1). This increase in mortality is due to the lack of receptors for three targetable growth factors (HER2, progesterone, and …
-
MESOTHELIN EXPRESSION AND TRIPLE-NEGATIVE BREAST CANCER
… biomarker, is more often overexpressed in triple receptor-negative breast cancer (TNBC) than in common luminal breast tumor subtype or normal tissues. The objective of this systematic review is to determine the association between the expressions of mesothelin with survival outcomes in …
-
Advancing Triple-Negative Breast Cancer Therapies with Mebendazole
Breast cancer is the most diagnosed cancer in women with one in every eight women predicted to develop this malignancy. Approximately 15-20% of all breast cancer is the highly invasive triple negative breast cancer (TNBC) which lacks estrogen, progesterone, and ERBB2 receptors. TNBC is difficult to …
-
c-Met/HGF in triple negative breast cancer
Triple negative breast cancer (TNBC) is a subtype of breast cancer which is negative for the oestrogen receptor, progesterone receptor and lacks over-expression of HER2. The aim of this PhD was to examine c-Met and its ligand HGF as potential targets for TNBC. Expression of c-Met was higher in TNBC …
-
Mineralocorticoid receptor signaling in Triple-negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of hormone receptors and HER2 (Human epidermal growth factor 2) receptor overexpression. Even in the face of initially effective treatments, TNBC patients relapse and develop therapy resistance. One …
-
Targeted Combination Therapy Of Triple-Negative Breast Cancer
TARGETED COMBINATION THERAPY OF TRIPLE-NEGATIVE BREAST CANCERby KETKI BHISE May 2021 Advisor: Dr. Arun Iyer Major: Pharmaceutical Sciences Degree: Doctor of Philosophy Triple Negative Breast Cancer (TNBC) accounts for 10-20% of the total breast carcinoma cases. There is no FDA-approved targeted …
-
Tyrosine Kinase Inhibitors in Triple Negative Breast Cancer
Basal-like breast cancers are generally negative for estrogen and progesterone receptor expression and HER-2 amplification (‘triple negative’ breast cancer, TNBC), and express basal cytokeratins 5/6, and EGFR (epidermal growth factor receptor). No targeted therapy options are currently approved for …
-
Mechanism of metastasis of triple negative breast cancer
Triple Negative Breast Cancer (TNBC) is increasingly recognised as a serious, worldwide public health concern. TNBC has the ability to recur after treatment and appears to be greatest in the first few years. The phenotypical changes of the TNBC metastasis represent a unique that heterogeneous …
-
NEW THERAPIES FOR CREB3L1-DEFICIENT TRIPLE NEGATIVE BREAST CANCER
ABSTRACT The lack of targeted therapies for triple-negative breast cancer (TNBC) contributes to their high mortality rates and high risk of relapse compared to other subtypes of breast cancer. Developing targeted therapies for TNBC is an unmet clinical need. Our lab has described metastasis …
-
Genetic Analysis of Triple-Negative Breast Cancer and Pineoblastoma
Metastatic triple-negative breast cancer (TNBC) is a devastating disease affecting relatively young women. The tumor suppressor genes TP53 and RB1 are commonly lost together in a subset of TNBC with exceedingly poor prognosis. The identification of oncogenic drivers that cooperate with p53/Rb-loss …
-
Targeting EGFR signalling pathway in triple negative breast cancer
… is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic responses of TNBC to the EGFR-targeted therapy, …
-
Targeting EGFR signalling pathway in triple negative breast cancer
… is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic responses of TNBC to the EGFR-targeted therapy, …
-
Adaptation to chronic hypoxia in triple-negative breast cancer
… tumours. Hypoxia is able to drive several of the cancer hallmarks and promotes resistance to both radio and chemotherapy, resulting in its association with poor prognosis. Triple-negative breast cancer has the worst prognosis of all breast cancer subtypes with a 5 year survival rate of only 76.7%, …
-
Platinum nanoparticles, targeted therapy for triple negative breast cancer
… that has many different applications including cancer treatment and detection. Noble metal nanoparticles such as gold, silver or palladium, have shown major potential in the field of medicine and pharmaceutics. In particular, platinum nanoparticles (Pt NPs) have been reported with promising …
-
Drug-loaded magnetoliposomes for triple negative breast cancer therapy
… promissores como transportadores de fármacos anticancerígenos, inibindo o crescimento de linhas celulares tumorais humanas. O cancro da mama triplo negativo (CMTN) é um subtipo de cancro da mama heterogéneo com elevado potencial metastático e resistência à quimioterapia convencional, o que destaca …
-
Regulation of Phenotypic Plasticity in Triple-Negative Breast Cancer
<p>Breast cancers with a basal-like gene signature are primarily triple-negative, are frequently metastatic, and carry the worst prognosis. Basal-like breast cancers are frequently enriched for markers of breast cancer stem cells as well as markers of epithelial-mesenchymal transition (EMT). While …
-
The role of IQGAP3 in triple negative breast cancer
Triple negative breast cancer refers to a spectrum of breast tumours which are characterised by the lack of overexpressing hormone or HER2 receptors. These tumours present as high grade and tend to have reduced progression free survival rates because of their aggressive and metastatic behaviour. …
Page 1 of 43